Hepatitis C and Human Immunodeficiency Virus Co-Infection in the Era of Direct-Acting Antiviral Agents: No Longer a Difficult to Treat Population

Hepatology - United States
doi 10.1002/hep.29642
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2014English

Direct-Acting Antiviral Drugs and Hepatitis C Virus: A Therapeutic Revolution?

Cancer
Cancer ResearchOncology
2015English

Statin (3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Inhibitor)-Based Therapy for Hepatitis C Virus (HCV) Infection-Related Diseases in the Era of Direct-Acting Antiviral Agents

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Two Cases of Hepatocellular Carcinoma Occurring Immediately After Direct-Acting Antiviral Agents Against Hepatitis C Virus

Internal Medicine
Internal MedicineMedicine
2019English

Barriers to Care for Chronic Hepatitis C in the Direct-Acting Antiviral Era: A Single-Centre Experience

BMJ Open Gastroenterology
Gastroenterology
2017English

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents

Frontiers in Medicine
Medicine
2019English

Concerns About Direct-Acting Antiviral Agents for Hepatitis C—Cause for Reassurance

JAMA network open
Medicine
2019English

Epidemiology of Hepatitis C Virus and Human Immunodeficiency Virus Co-Infection and Challenges in Their Diagnosis

Journal of Microbiology and Infectious Diseases
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy